Literature DB >> 1705212

Transcriptional regulation studies of myelin-associated genes in myelin-deficient mutant rats.

S Kumar1, W B Macklin, M N Gordon, A Espinosa de los Monteros, R Cole, S A Scully, J de Vellis.   

Abstract

To identify and assess the consequences of the mutation in myelin-deficient (md) rats, the myelin proteolipid protein (PLP) gene and its expression were studied in md rats. Southern blots of the PLP gene demonstrated that no major deletions or insertions have occurred in this gene. In addition, the mutation in this gene does not result in a splicing defect in the RNAs, since all exons are represented in md PLP RNAs. These data are consistent with results in another laboratory indicating that a point mutation in the PLP gene in md rats results in a single amino acid alteration in the protein. To elucidate the molecular mechanisms producing reduced levels of PLP, myelin basic protein (MBP) and glycerol phosphate dehydrogenase (GPDH) mRNAs, and their corresponding proteins in md rats, in vitro transcription assays were performed. Transcription of the PLP gene in nuclei isolated from 23-day-old md rat brains was dramatically reduced relative to normal tissue. Thus, the single amino acid alteration in this protein alters the regulation of transcription of this gene. In contrast, the transcriptional activities of the MBP and GPDH genes in md rats were indistinguishable from normal animals. Thus, the lower level of MBP and GPDH mRNA and protein in md rats relative to normal results from a posttranscriptional event.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1705212     DOI: 10.1159/000111860

Source DB:  PubMed          Journal:  Dev Neurosci        ISSN: 0378-5866            Impact factor:   2.984


  8 in total

1.  O2A progenitor cells transplanted into the neonatal rat brain develop into oligodendrocytes but not astrocytes.

Authors:  A Espinosa de los Monteros; M Zhang; J De Vellis
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-01       Impact factor: 11.205

2.  Delayed Maturation of Oligodendrocyte Progenitors by Microgravity: Implications for Multiple Sclerosis and Space Flight.

Authors:  Victoria Tran; Nicholas Carpo; Sophia Shaka; Joile Zamudio; Sungshin Choi; Carlos Cepeda; Araceli Espinosa-Jeffrey
Journal:  Life (Basel)       Date:  2022-05-27

3.  Transferrin is an essential factor for myelination.

Authors:  A Espinosa de los Monteros; S Kumar; P Zhao; C J Huang; R Nazarian; T Pan; S Scully; R Chang; J de Vellis
Journal:  Neurochem Res       Date:  1999-02       Impact factor: 3.996

4.  Glucocorticoid regulation of glycerolphosphate dehydrogenase expression in the developing rat brain.

Authors:  E Kitraki; M N Alexis; F Stylianopoulou
Journal:  Neurochem Res       Date:  1995-03       Impact factor: 3.996

5.  Mutation in the myelin proteolipid protein gene alters BK and SK channel function in the caudal medulla.

Authors:  Catherine A Mayer; Wendy B Macklin; Nanthawan Avishai; Kannan Balan; Christopher G Wilson; Martha J Miller
Journal:  Respir Physiol Neurobiol       Date:  2009-10-04       Impact factor: 1.931

6.  Proteolipid protein gene mutation induces altered ventilatory response to hypoxia in the myelin-deficient rat.

Authors:  Martha J Miller; Musa A Haxhiu; Paraskevi Georgiadis; Tatyana I Gudz; Cindy D Kangas; Wendy B Macklin
Journal:  J Neurosci       Date:  2003-03-15       Impact factor: 6.167

7.  White matter loss in a mouse model of periventricular leukomalacia is rescued by trophic factors.

Authors:  Araceli Espinosa-Jeffrey; Socorro A R Barajas; Alfonso R Arrazola; Alana Taniguchi; Paul M Zhao; Payam Bokhoor; Sandra M Holley; Don P Dejarme; Brian Chu; Carlos Cepeda; Michael S Levine; Pierre Gressens; Alfredo Feria-Velasco; Jean de Vellis
Journal:  Brain Sci       Date:  2013-11-12

8.  Impact of simulated microgravity on oligodendrocyte development: implications for central nervous system repair.

Authors:  Araceli Espinosa-Jeffrey; Pablo M Paez; Veronica T Cheli; Vilma Spreuer; Ina Wanner; Jean de Vellis
Journal:  PLoS One       Date:  2013-12-04       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.